OVB Tag

Ovoca Bio PLC – OVB – Interim Results

Dublin, Ireland, 21 September, 2020 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, is pleased to announce its interim financial statements and report covering the six-months...

Read More

Ovoca Bio PLC – Interim Results

Ovoca Bio, a biopharmaceutical company focused on identifying and developing novel therapeutics targeting the large unmet needs in the treatment of female sexual dysfunction, is pleased to announce its interim...

Read More

Ovoca Bio PLC – Directorate Change

Ovoca Bio plc (LSE: OVB; ISE: OVXA) announces that Nikolay Myasoyedov, a Non-Executive Director of the Company, has notified the board of his intention to step down from the board...

Read More

Ovoca Bio PLC – AGM Statement

Ovoca Bio plc (LSE: OVB; ISE: OVXA) will hold its Annual General Meeting ("AGM") at 12.00 p.m. today at Buswells Hotel, 23-25 Molesworth Steet, Dublin, Ireland. At the AGM, Kirill...

Read More

Ovoca Bio PLC – Operational Update

Ovoca Bio plc (LSE: OVB) is pleased to provide an operating update relating to its subsidiary, IVIX LLC (IVIX), and confirmation of the acquisition of an additional interest in IVIX...

Read More